| 1 |
33585479 | Excessive All-Trans Retinoic Acid Inhibits Cell Proliferation Through Upregulated MicroRNA-4680-3p in Cultured Human Palate Cells. | 2021 |
2 |
| 2 |
31619506 | A TFAP2C Gene Signature Is Predictive of Outcome in HER2-Positive Breast Cancer. | 2020 Jan |
1 |
| 3 |
30431066 | Bioinformatics-based study to detect chemical compounds that show potential as treatments for pulmonary thromboembolism. | 2019 Jan |
1 |
| 4 |
29899874 | Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells. | 2018 May 29 |
2 |
| 5 |
28592877 | ω-3 free fatty acids and all-trans retinoic acid synergistically induce growth inhibition of three subtypes of breast cancer cell lines. | 2017 Jun 7 |
1 |
| 6 |
27074819 | The HER2 inhibitor TAK165 Sensitizes Human Acute Myeloid Leukemia Cells to Retinoic Acid-Induced Myeloid Differentiation by activating MEK/ERK mediated RARα/STAT1 axis. | 2016 Apr 14 |
2 |
| 7 |
25631875 | Addition of all-trans-retinoic acid to omeprazole and sucralfate therapy improves the prognosis of gastric dysplasia. | 2015 Apr |
1 |
| 8 |
25961594 | MicroRNA networks regulated by all-trans retinoic acid and Lapatinib control the growth, survival and motility of breast cancer cells. | 2015 May 30 |
2 |
| 9 |
26133921 | Histone deacetylase inhibitor entinostat in combination with a retinoid downregulates HER2 and reduces the tumor initiating cell population in aromatase inhibitor-resistant breast cancer. | 2015 Aug |
4 |
| 10 |
23830798 | Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers. | 2013 Oct |
1 |
| 11 |
22056878 | Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARA. | 2012 Jul 19 |
2 |
| 12 |
20696059 | Anti-tumor effects of retinoids combined with trastuzumab or tamoxifen in breast cancer cells: induction of apoptosis by retinoid/trastuzumab combinations. | 2010 |
2 |
| 13 |
16752155 | Retinoic acid elicits cytostatic, cytotoxic and immunomodulatory effects on uveal melanoma cells. | 2007 Feb |
1 |
| 14 |
15375520 | The HER2/Grb2/Akt pathway regulates the DNA binding activity of AP-1 in breast cancer cells. | 2004 Oct |
3 |
| 15 |
14612949 | HER2/neu uses Akt to suppress retinoic acid response element binding activity in MDA-MB-453 breast cancer cells. | 2003 Dec |
6 |
| 16 |
12063559 | Preventive efficacy of receptor class selective retinoids on HER-2/neu oncogene expressing preneoplastic human mammary epithelial cells. | 2002 Jul |
3 |
| 17 |
12149644 | Her2/neu induces all-trans retinoic acid (ATRA) resistance in breast cancer cells. | 2002 Aug 8 |
9 |
| 18 |
12595744 | N-(4-hydroxyphenyl)-retinamide selectively increases All-TRANS retinoic acid inhibitory effects in HER2/NEU-overexpressing breast cancer cells. | 2002 Sep-Oct |
6 |
| 19 |
10664247 | Effects of all-trans retinoic acid and epidermal growth factor on the expression of nm23-H1 in human hepatocarcinoma cells. | 2000 Feb |
1 |
| 20 |
10383375 | Expression of c-erbB-4/HER4 is regulated in T47D breast carcinoma cells by retinoids and vitamin D3. | 1999 May 19 |
1 |
| 21 |
9662255 | Effects of retinoic acid and fenretinide on the c-erbB-2 expression, growth and cisplatin sensitivity of breast cancer cells. | 1998 Jul |
3 |
| 22 |
9791009 | Retinoids control the expression of c-erbB receptors in breast cancer cells. | 1998 Oct 29 |
3 |
| 23 |
7906679 | erbB-2 expression in estrogen-receptor-positive breast-tumor cells is regulated by growth-modulatory reagents. | 1994 Feb 15 |
1 |